CHIEF COMPLAINT: “I can’t catch my breath.” • HPI: Nina Orendorff is an 83-year-old woman who presented to the ED with generalized complaints, feeling run down and unable to breathe. When evaluated by the ED nursing staff, her heart rate was in the range of 110–120 beats per minute. The patient states that she has had progressively worsening dyspnea on exertion over the last 2 weeks. Her shortness of breath has severely limited her activities and has increased to persist even at rest • PMH: Type 2 DM times 5 years, diet controlled, HTN times 40 years • FH: Father died at age 85 of “old age”; mother died at 88 after a hip fracture; one brother (age 80) alive with no significant history • SH: Retired schoolteacher who lives at home alone; reports enjoying a cocktail while playing cards with friends • MEDS: Minoxidil 10 mg po bid • ALLERGY: NKDA • ROS GEN: Patient reports a recent weight gain along with a general reduction in her state of health primarily related to an inability to get around as she usually has in the past. CV: She has no complaints of any chest pain but does report dyspnea on exertion, as well as orthopnea and paroxysmal nocturnal dyspnea. She has noted peripheral edema. RESP: She reports shortness of breath and a new cough that is not productive. She has not had any recent respiratory infections. GI: She reports no recent changes in bowel habits. GU: No complaints MS: No complaints of MS pain or weakness, just a general inability to exercise secondary to becoming “winded” NEURO: No abnormalities noted Physical Examination GEN: The patient is sitting up on the gurney in the ED in moderate distress. VS: BP 150/100, P 100–130 (regular), RR 28, T 35deg C; Wt 73 kg (usual weight 65 kg), Ht 5’3′ SKIN: Color pale; no unusual lesions noted HEENT: PERRLA, EOMI, fundi were not examined. She has complete dentition, and her teeth are in fair repair. NECK: (+) JVD at 30deg (6 cm). Carotid bruit is not appreciated. No lymphadenopathy or thyromegaly LUNGS/THORAX: Respirations are even. There are crackles in both lung fields posteriorly noted one-third of the way up the lung fields. There is no CVAT. HEART: Regular rhythm, no rubs, variation in intensity of S1 as expected; S3 appreciated at the apex in the lateral position; PMI displaced laterally and difficult to discern ABD: Soft, NT/ND; (+) HJR; liver and spleen slightly enlarged; no masses; hypoactive bowel sounds GENIT/RECT: Guaiac (–), genital examination not performed MS/EXT: 2+ pitting pedal edema bilaterally; radial and pedal pulses are of poor intensity bilaterally; grip strength even NEURO: A & O times 3; CNs intact; DTR intact • LABS • ECG: Sinus tachycardia rate of 112; QRS 0.08; diffuse nonspecific ST-T wave changes; low voltage • CXR: PA and lateral views (see Fig. 9-1) show evidence of interstitial edema and some early alveolar edema • ASSESSMENT: Diet-controlled patient with Type 2 DM and new-onset congestive heart failure • CLINICAL COURSE: The patient was admitted to a telemetry unit. A 2D echocardiogram was obtained to evaluate LV and valvular function. Results revealed evidence of impaired ventricular relaxation and elevated left atrial filling pressures consistent with grade II diastolic dysfunction. EF was estimated at 45–50%; there was no evidence of mitral stenosis or pericardial disease. QUESTIONS Problem Identification 1.a. Create a list of this patient’s drug-related problems. 1.b. What signs, symptoms, and other information indicate the presence and severity of the patient’s heart failure? 1.c. What are the classification and staging of this patient’s heart failure upon presentation? 1.d. Could any of this patient’s problems have been caused by drug therapy? Desired Outcome 2.a. What are the goals for the pharmacologic management of heart failure in this patient? 2.b. Considering her other medical problems, what other treatment goals should be established? Therapeutic Alternatives 3. What medications are indicated in the long-term management of this patient’s heart failure based on her stage of heart failure? Optimal Plan 4. What drugs, doses, schedules, and duration are best suited for the management of this patient? Outcome Evaluation 5. What clinical and laboratory parameters are needed to evaluate the therapy for achievement of the desired therapeutic outcome and to detect and prevent adverse events? • CLINICAL COURSE: Over the next 3 days, the patient received maximal drug therapy, and her condition improved. She was discharged on lisinopril 20 mg po daily, metoprolol 25 mg po bid, furosemide 40 mg po daily, and aspirin 325 mg po daily. Patient Education 6. What information should be provided to the patient about the medications used to treat her heart failure? • CLINICAL COURSE: On follow-up with her geriatrician, the patient is noted to have sustained a 2-kg weight gain from baseline dry weight at discharge. Her exercise tolerance and ability to conduct activities of daily living have improved, FOLLOW-UP QUESTIONS 1. Outline a plan for maximizing the patient’s current medication regimen for heart failure. 2. Outline a therapeutic plan for titration of metoprolol for this patient. 3. What common adverse effects should be anticipated with metoprolol, and how should they be managed if they occur? • CLINICAL COURSE: The patient returns to your geriatric clinic 2 weeks later, stating that her weight is improved. Despite this improvement, her blood pressure is now 100/50 mm Hg, her heart rate is 100–110 beats per minute, and she still has symptoms. 4. You suspect the patient may have been overdiuresed. What impact might this have on the patient?
[Verified Answer]: CHIEF COMPLAINT: “I can’t catch my breath
Need help with your Cardiovascular Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.